High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia

Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia

(2018) Zhiheng Cheng et al.   CANCER GENE THERAPY

Advances in treatment formulations for acute myeloid leukemia

(2018) Thomas Briot et al.   DRUG DISCOVERY TODAY

Prognostic role of DOK family adapters in acute myeloid leukemia

(2018) Lin Zhang et al.   CANCER GENE THERAPY

Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia

(2018) Longzhen Cui et al.   CANCER GENE THERAPY

Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy

(2017) Yang Jia et al.   Thoracic Cancer

Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment

(2016) Maximilian Fleischmann et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells

(2016) Bao-Yan Liu et al.   Oncology Letters

Acute Myeloid Leukemia

(2015) Hartmut Döhner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Which Acute Myeloid Leukemia Patients Should Be Offered Transplantation?

(2015) Eolia Brissot et al.   SEMINARS IN HEMATOLOGY

Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer

(2014) JUN HU et al.   ONCOLOGY REPORTS

The role of IFITM3 in the growth and migration of human glioma cells

(2013) Bing Zhao et al.   BMC Neurology

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle

(2013) MEI YANG et al.   ONCOLOGY REPORTS

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

(2012) Annika Dufour et al.   ANNALS OF HEMATOLOGY

Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes

(2012) Felicitas Thol et al.   ANNALS OF HEMATOLOGY

Evolution of vertebrate interferon inducible transmembrane proteins

(2012) Danielle Hickford et al.   BMC GENOMICS

CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis

(2012) Mohamed M. Awad et al.   Hematology

Age-Related Prognostic Impact of Different Types ofDNMT3AMutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia

(2012) Guido Marcucci et al.   JOURNAL OF CLINICAL ONCOLOGY

RUNX1Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

(2012) Jason H. Mendler et al.   JOURNAL OF CLINICAL ONCOLOGY

DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications

(2011) H.-A. Hou et al.   BLOOD

KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis

(2011) D. Li et al.   CLINICAL CANCER RESEARCH

Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells

(2011) U. Bacher et al.   HAEMATOLOGICA

The human1-8Dgene (IFITM2) is a novelp53independent pro-apoptotic gene

(2009) Vered Daniel-Carmi et al.   INTERNATIONAL JOURNAL OF CANCER

IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression

(2008) H. Hatano et al.   CLINICAL CANCER RESEARCH